The Cigna Group (CI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,489,000 | 5,120,000 | 2,646,000 | 2,232,000 | 1,843,000 |
| Depreciation Amortization | 2,802,000 | 3,651,000 | 695,000 | 566,000 | 610,000 |
| Income taxes - deferred | -386,000 | -313,000 | -101,000 | 242,000 | 74,000 |
| Accounts payable and accrued liabilities | 4,237,000 | 1,151,000 | -510,000 | 731,000 | 125,000 |
| Other Working Capital | 3,598,000 | 1,202,000 | 449,000 | 962,000 | 1,668,000 |
| Other Operating Activity | -8,390,000 | -1,326,000 | 591,000 | -647,000 | -294,000 |
| Operating Cash Flow | $10,350,000 | $9,485,000 | $3,770,000 | $4,086,000 | $4,026,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,094,000 | -1,050,000 | -528,000 | -471,000 | -461,000 |
| Net Acquisitions | 5,453,000 | -153,000 | -24,455,000 | -209,000 | -4,000 |
| Purchase Of Investment | -6,802,000 | -6,342,000 | -7,138,000 | -7,123,000 | -7,054,000 |
| Sale Of Investment | 5,396,000 | 6,822,000 | 5,755,000 | 6,100,000 | 5,046,000 |
| Other Investing Activity | 23,000 | -11,000 | -12,000 | 0 | -101,000 |
| Investing Cash Flow | $2,976,000 | $-734,000 | $-26,378,000 | $-1,703,000 | $-2,574,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 60,000 | -681,000 | 1,487,000 | 80,000 | -148,000 |
| Debt Issued | 4,863,000 | 0 | 22,856,000 | 1,581,000 | N/A |
| Debt Repayment | -9,659,000 | -4,494,000 | -131,000 | -1,563,000 | N/A |
| Common Stock Issued | 376,000 | 224,000 | 68,000 | 131,000 | 36,000 |
| Common Stock Repurchased | -4,042,000 | -1,987,000 | -342,000 | -2,725,000 | -139,000 |
| Dividend Paid | -15,000 | -15,000 | N/A | N/A | N/A |
| Other Financing Activity | -116,000 | -234,000 | -423,000 | -155,000 | 26,000 |
| Financing Cash Flow | $-8,533,000 | $-7,187,000 | $23,515,000 | $-2,651,000 | $-225,000 |
| Exchange Rate Effect | 41,000 | -8,000 | -24,000 | 55,000 | -10,000 |
| Beginning Cash Position | 5,411,000 | 3,855,000 | 2,972,000 | 3,185,000 | 1,968,000 |
| End Cash Position | 10,245,000 | 5,411,000 | 3,855,000 | 2,972,000 | 3,185,000 |
| Net Cash Flow | $4,834,000 | $1,556,000 | $883,000 | $-213,000 | $1,217,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,350,000 | 9,485,000 | 3,770,000 | 4,086,000 | 4,026,000 |
| Capital Expenditure | -1,094,000 | -1,050,000 | -528,000 | -471,000 | -461,000 |
| Free Cash Flow | 9,256,000 | 8,435,000 | 3,242,000 | 3,615,000 | 3,565,000 |